0.0005
0.0000
(0.00%)
As of 8:20:06 AM GMT+2. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Matthew Robert Leonard | MD & Executive Director | 77.14k | -- | -- |
| Mr. Francesco Cannavo | Part-Time Executive Director | 75.17k | -- | -- |
| Mr. Chow-Yee Koh | Chief Financial Officer | 123.56k | -- | 1976 |
| Mr. Justyn Peter Stedwell B.Com, B.Com. | Company Secretary | -- | -- | 1981 |
BPH Global Ltd
Block Arcade, 96 Elizabeth St.
Level 3 Office 324
Melbourne, VIC 3000
Australia
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
Corporate Governance
BPH Global Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 6, 2025 at 10:59 AM UTC
BPH Global Ltd Earnings Date
Recent Events
Recent Events Information Not Available